Symbols / NNOX Stock $1.72 -2.82% Nano-X Imaging Ltd.

Healthcare • Medical Devices • Israel • NGM
NNOX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Erez I. Meltzer
Exch · Country NGM · Israel
Market Cap 119.70M
Enterprise Value 67.94M
Income -75.02M
Sales 13.02M
FCF (ttm) -25.29M
Book/sh 2.01
Cash/sh 0.86
Employees 197
Insider 10d —
IPO Aug 21, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -34.40
PEG —
P/S 9.19
P/B 0.86
P/C —
EV/EBITDA -1.39
EV/Sales 5.22
Quick Ratio 3.65
Current Ratio 3.96
Debt/Eq 5.62
LT Debt/Eq —
EPS (ttm) -1.16
EPS next Y -0.05
EPS Growth —
Revenue Growth 24.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-21
Earnings (prior) 2026-04-20
ROA -20.37%
ROE -45.62%
ROIC —
Gross Margin -98.21%
Oper. Margin -4.79%
Profit Margin 0.00%
Shs Outstand 69.59M
Shs Float 69.38M
Insider Own 0.35%
Instit Own 26.39%
Short Float 19.02%
Short Ratio 6.43
Short Interest 13.20M
52W High 5.72
vs 52W High -69.93%
52W Low 1.59
vs 52W Low 8.18%
Beta 1.18
Impl. Vol. 1.56%
Rel Volume 0.68
Avg Volume 1.32M
Volume 904.36K
Target (mean) $6.65
Tgt Median $6.00
Tgt Low $5.00
Tgt High $9.60
# Analysts 4
Recom None
Prev Close $1.77
Price $1.72
Change -2.82%
About

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence–based solution; AI-Based Body Composition Measurement, an artificial intelligence–based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.65
Mean price target
2. Current target
$1.72
Latest analyst target
3. DCF / Fair value
$-6.54
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.72
Low
$5.00
High
$9.60
Mean
$6.65

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-20 main D. Boral Capital Buy → Buy $5
2026-04-13 main D. Boral Capital Buy → Buy $5
2026-03-03 main D. Boral Capital Buy → Buy $5
2026-02-04 main D. Boral Capital Buy → Buy $5
2025-11-20 main D. Boral Capital Buy → Buy $8
2025-11-18 main D. Boral Capital Buy → Buy $8
2025-09-19 main D. Boral Capital Buy → Buy $8
2025-08-13 main D. Boral Capital Buy → Buy $8
2025-06-06 main D. Boral Capital Buy → Buy $10
2025-05-23 main D. Boral Capital Buy → Buy $10
2025-04-17 main D. Boral Capital Buy → Buy $15
2025-04-01 main Cantor Fitzgerald Overweight → Overweight $9
2025-03-31 main D. Boral Capital Buy → Buy $15
2025-02-25 main D. Boral Capital Buy → Buy $23
2025-01-06 init D. Boral Capital — → Buy $23
2024-12-06 main Cantor Fitzgerald Overweight → Overweight $12
2024-11-26 main Cantor Fitzgerald Overweight → Overweight $11
2024-09-23 reit Cantor Fitzgerald Overweight → Overweight $14
2024-05-31 reit Cantor Fitzgerald Overweight → Overweight $17
2024-05-30 main Cantor Fitzgerald Overweight → Overweight $17
News
RSS: Latest NNOX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-09-05 DANIEL RAN Chief Financial Officer — 1,000 $3.65 $3,650
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
13.02
+15.40%
11.28
+13.91%
9.90
+15.47%
8.58
Operating Revenue
13.02
+15.40%
11.28
+13.91%
9.90
+15.47%
8.58
Cost Of Revenue
25.81
+17.89%
21.89
+32.70%
16.50
+6.72%
15.46
Reconciled Cost Of Revenue
14.27
+38.83%
10.28
-37.72%
16.50
+6.72%
15.46
Gross Profit
-12.79
-20.54%
-10.61
-60.94%
-6.59
+4.19%
-6.88
Operating Expense
47.91
+3.85%
46.14
-13.06%
53.06
-33.94%
80.33
Research And Development
19.24
-4.69%
20.18
-22.52%
26.05
-1.73%
26.51
Selling General And Administration
27.10
+5.24%
25.75
-9.46%
28.44
-37.67%
45.63
Selling And Marketing Expense
2.63
+59.41%
1.65
-60.34%
4.17
-4.75%
4.38
General And Administrative Expense
24.46
+1.53%
24.10
-0.73%
24.27
-41.16%
41.25
Salaries And Wages
13.89
+6.16%
13.08
+6.90%
12.24
-46.87%
23.03
Other Gand A
8.29
+5.22%
7.88
-67.55%
24.27
-41.16%
41.25
Other Operating Expenses
1.42
+1481.11%
0.09
+106.32%
-1.42
-117.38%
8.19
Total Expenses
73.72
+8.37%
68.03
-2.20%
69.56
-27.38%
95.79
Operating Income
-60.70
-6.97%
-56.75
+4.88%
-59.66
+31.59%
-87.21
Total Operating Income As Reported
-78.23
-37.87%
-56.75
+9.34%
-62.59
+46.83%
-117.71
EBITDA
-49.00
-8.86%
-45.01
+5.92%
-47.85
+36.79%
-75.70
Normalized EBITDA
-31.47
+30.10%
-45.02
-0.62%
-44.74
+1.01%
-45.19
Reconciled Depreciation
11.70
-0.31%
11.73
-0.65%
11.81
+2.59%
11.51
EBIT
-60.70
-6.97%
-56.75
+4.88%
-59.66
+31.59%
-87.21
Total Unusual Items
-17.54
-876850.00%
0.00
+100.06%
-3.11
+89.80%
-30.50
Total Unusual Items Excluding Goodwill
-17.54
-876850.00%
0.00
+100.06%
-3.11
+89.80%
-30.50
Special Income Charges
-17.54
0.00
+100.00%
-2.93
+90.39%
-30.50
Impairment Of Capital Assets
17.53
0.00
-100.00%
7.42
-85.42%
50.88
Restructuring And Mergern Acquisition
0.01
0.00
+100.00%
-4.49
+77.97%
-20.38
Net Income
-75.02
-40.18%
-53.52
+11.95%
-60.78
+46.33%
-113.24
Pretax Income
-76.81
-42.57%
-53.87
+11.85%
-61.12
+47.73%
-116.92
Net Non Operating Interest Income Expense
1.42
-50.38%
2.87
+73.73%
1.65
+109.38%
0.79
Net Interest Income
1.42
-50.38%
2.87
+73.73%
1.65
+109.38%
0.79
Interest Income Non Operating
1.42
-50.38%
2.87
+73.73%
1.65
+109.38%
0.79
Interest Income
1.42
-50.38%
2.87
+73.73%
1.65
+109.38%
0.79
Other Income Expense
-17.54
-876850.00%
0.00
+100.06%
-3.11
+89.80%
-30.50
Gain On Sale Of Security
—
0.00
+101.12%
-0.18
—
Tax Provision
-1.79
-400.56%
-0.36
-5.60%
-0.34
+90.78%
-3.68
Tax Rate For Calcs
0.00
+251.09%
0.00
+19.79%
0.00
-82.37%
0.00
Tax Effect Of Unusual Items
-0.41
-3078267.20%
0.00
+100.08%
-0.02
+98.20%
-0.96
Net Income Including Noncontrolling Interests
-75.02
-40.18%
-53.52
+11.95%
-60.78
+46.33%
-113.24
Net Income From Continuing Operation Net Minority Interest
-75.02
-40.18%
-53.52
+11.95%
-60.78
+46.33%
-113.24
Net Income From Continuing And Discontinued Operation
-75.02
-40.18%
-53.52
+11.95%
-60.78
+46.33%
-113.24
Net Income Continuous Operations
-75.02
-40.18%
-53.52
+11.95%
-60.78
+46.33%
-113.24
Normalized Income
-57.89
-8.17%
-53.52
+7.22%
-57.68
+31.08%
-83.70
Net Income Common Stockholders
-75.02
-40.18%
-53.52
+11.95%
-60.78
+46.33%
-113.24
Diluted EPS
-1.16
-27.47%
-0.91
+15.74%
-1.08
+46.27%
-2.01
Basic EPS
-1.16
-27.47%
-0.91
+15.74%
-1.08
+46.27%
-2.01
Basic Average Shares
64.79
+10.43%
58.67
+4.09%
56.37
+7.91%
52.23
Diluted Average Shares
64.79
+10.43%
58.67
+4.09%
56.37
+7.91%
52.23
Diluted NI Availto Com Stockholders
-75.02
-40.18%
-53.52
+11.95%
-60.78
+46.33%
-113.24
Depreciation Amortization Depletion Income Statement
0.15
+31.90%
0.12
+152.17%
0.05
-86.97%
0.35
Depreciation And Amortization In Income Statement
0.15
+31.90%
0.12
+152.17%
0.05
-86.97%
0.35
Insurance And Claims
0.82
-43.30%
1.45
-49.26%
2.85
-31.05%
4.14
Rent And Landing Fees
1.47
-13.12%
1.69
+76.25%
0.96
+32.96%
0.72
Rent Expense Supplemental
1.47
-13.12%
1.69
+76.25%
0.96
+32.96%
0.72
Total Other Finance Cost
—
—
—
-0.79
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
162.16
-22.78%
210.00
-3.95%
218.65
-13.90%
253.93
Current Assets
66.79
-15.11%
78.68
-11.23%
88.64
+7.49%
82.46
Cash Cash Equivalents And Short Term Investments
59.61
-18.57%
73.21
-11.14%
82.38
+6.13%
77.62
Cash And Cash Equivalents
49.15
+25.05%
39.30
-30.28%
56.38
+46.57%
38.46
Other Short Term Investments
10.46
-69.15%
33.90
+30.36%
26.01
-33.59%
39.16
Receivables
2.01
+11.52%
1.80
+21.63%
1.48
+51.89%
0.98
Accounts Receivable
2.01
+11.52%
1.80
+21.63%
1.48
+51.89%
0.98
Gross Accounts Receivable
2.38
+24.15%
1.92
+24.56%
1.54
+52.23%
1.01
Allowance For Doubtful Accounts Receivable
-0.37
-227.68%
-0.11
-103.64%
-0.06
-61.76%
-0.03
Inventory
3.07
+105.63%
1.49
-36.63%
2.36
0.00
Raw Materials
1.34
+65.97%
0.81
-51.53%
1.67
0.00
Finished Goods
1.73
+152.41%
0.69
-0.58%
0.69
0.00
Prepaid Assets
1.25
+51.75%
0.83
-35.09%
1.27
-47.22%
2.41
Restricted Cash
—
0.00
-100.00%
0.05
0.00
Other Current Assets
0.84
-37.36%
1.35
+23.53%
1.09
-24.48%
1.45
Total Non Current Assets
95.37
-27.38%
131.32
+1.01%
130.01
-24.18%
171.47
Net PPE
33.20
-32.53%
49.20
+4.86%
46.92
+4.95%
44.70
Gross PPE
38.82
-29.27%
54.88
+10.62%
49.61
+6.99%
46.37
Accumulated Depreciation
-5.62
+1.00%
-5.68
-111.04%
-2.69
-61.82%
-1.66
Properties
0.00
0.00
0.00
0.00
Land And Improvements
6.31
+0.00%
6.31
+0.00%
6.31
+0.00%
6.31
Machinery Furniture Equipment
8.98
+47.33%
6.10
+42.92%
4.27
-34.44%
6.51
Construction In Progress
12.30
-63.46%
33.66
+4.47%
32.22
+1.51%
31.74
Other Properties
10.01
+30.36%
7.68
+29.03%
5.95
+414.52%
1.16
Leases
1.21
+7.28%
1.13
+31.85%
0.85
+31.99%
0.65
Goodwill And Other Intangible Assets
60.18
-14.02%
70.00
-13.17%
80.61
-18.28%
98.64
Goodwill
0.32
0.00
0.00
-100.00%
7.42
Other Intangible Assets
59.87
-14.47%
70.00
-13.17%
80.61
-11.63%
91.22
Investments And Advances
—
—
0.00
-100.00%
25.20
Non Current Prepaid Assets
0.00
-100.00%
10.00
0.00
—
Other Non Current Assets
1.99
-6.39%
2.13
-14.50%
2.49
-15.10%
2.93
Total Liabilities Net Minority Interest
22.43
+7.42%
20.88
-9.73%
23.13
-37.90%
37.25
Current Liabilities
16.89
+20.87%
13.97
-10.00%
15.52
-38.09%
25.07
Payables And Accrued Expenses
7.11
+15.10%
6.18
-14.48%
7.22
-54.45%
15.86
Payables
2.89
+30.65%
2.21
-33.12%
3.30
-8.73%
3.62
Accounts Payable
2.89
+30.65%
2.21
-33.12%
3.30
-8.73%
3.62
Current Accrued Expenses
4.22
+6.45%
3.97
+1.22%
3.92
-67.97%
12.24
Current Debt And Capital Lease Obligation
4.09
+7.36%
3.81
-12.53%
4.35
+487.97%
0.74
Current Debt
3.14
+2.45%
3.06
-12.29%
3.49
—
Other Current Borrowings
—
3.06
-12.29%
3.49
—
Current Capital Lease Obligation
0.95
+27.52%
0.74
-13.47%
0.86
+16.35%
0.74
Current Deferred Liabilities
0.53
+281.43%
0.14
-74.22%
0.54
+198.35%
0.18
Current Deferred Revenue
0.53
+281.43%
0.14
-74.22%
0.54
+198.35%
0.18
Other Current Liabilities
5.16
+34.01%
3.85
+12.97%
3.41
-58.92%
8.29
Total Non Current Liabilities Net Minority Interest
5.54
-19.77%
6.91
-9.19%
7.61
-37.52%
12.18
Long Term Debt And Capital Lease Obligation
3.77
+3.43%
3.64
-10.01%
4.04
+4.28%
3.88
Long Term Debt
—
—
—
3.48
Long Term Capital Lease Obligation
3.77
+3.43%
3.64
-10.01%
4.04
+916.33%
0.40
Non Current Deferred Liabilities
0.62
-76.05%
2.58
-12.77%
2.95
-20.79%
3.73
Non Current Deferred Revenue
0.02
0.00
0.00
-100.00%
0.40
Non Current Deferred Taxes Liabilities
0.60
-76.71%
2.58
-12.77%
2.95
-11.32%
3.33
Other Non Current Liabilities
1.16
+67.34%
0.69
+13.56%
0.61
-86.61%
4.57
Stockholders Equity
139.73
-26.11%
189.12
-3.27%
195.51
-9.77%
216.68
Common Stock Equity
139.73
-26.11%
189.12
-3.27%
195.51
-9.77%
216.68
Capital Stock
0.20
+9.39%
0.18
+9.70%
0.17
+4.43%
0.16
Common Stock
0.20
+9.39%
0.18
+9.70%
0.17
+4.43%
0.16
Share Issued
69.59
+9.14%
63.76
+10.36%
57.78
+4.87%
55.09
Ordinary Shares Number
69.59
+9.14%
63.76
+10.36%
57.78
+4.87%
55.09
Additional Paid In Capital
588.30
+4.55%
562.69
+9.07%
515.89
+7.94%
477.95
Retained Earnings
-448.77
-20.07%
-373.75
-16.71%
-320.23
-23.42%
-259.46
Gains Losses Not Affecting Retained Earnings
0.00
+100.00%
-0.00
+99.67%
-0.30
+84.55%
-1.97
Other Equity Adjustments
—
-0.00
+99.67%
-0.30
+84.55%
-1.97
Total Equity Gross Minority Interest
139.73
-26.11%
189.12
-3.27%
195.51
-9.77%
216.68
Total Capitalization
139.73
-26.11%
189.12
-3.27%
195.51
-11.19%
220.16
Working Capital
49.91
-22.88%
64.71
-11.49%
73.11
+27.40%
57.39
Invested Capital
142.87
-25.66%
192.18
-3.43%
199.00
-9.61%
220.16
Total Debt
7.85
+5.44%
7.45
-11.31%
8.40
+81.77%
4.62
Capital Lease Obligations
4.71
+7.53%
4.38
-10.62%
4.91
+331.11%
1.14
Net Tangible Assets
79.55
-33.22%
119.12
+3.67%
114.91
-2.66%
118.04
Tangible Book Value
79.55
-33.22%
119.12
+3.67%
114.91
-2.66%
118.04
Available For Sale Securities
—
—
—
25.20
Investmentin Financial Assets
—
—
0.00
-100.00%
25.20
Line Of Credit
3.14
+2.45%
3.06
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-40.79
-11.46%
-36.60
+18.27%
-44.78
-3.21%
-43.38
Cash Flow From Continuing Operating Activities
-40.79
-11.46%
-36.60
+18.27%
-44.78
-3.21%
-43.38
Net Income From Continuing Operations
-75.02
-40.18%
-53.52
+11.95%
-60.78
+46.33%
-113.24
Depreciation Amortization Depletion
11.70
-0.31%
11.73
-0.65%
11.81
+2.59%
11.51
Depreciation
1.19
+6.07%
1.12
-6.43%
1.20
+32.38%
0.91
Amortization Cash Flow
10.51
-0.98%
10.61
+0.00%
10.61
+0.05%
10.61
Depreciation And Amortization
11.70
-0.31%
11.73
-0.65%
11.81
+2.59%
11.51
Amortization Of Intangibles
10.51
-0.98%
10.61
+0.00%
10.61
+0.05%
10.61
Other Non Cash Items
-0.45
—
-4.49
+77.97%
-20.38
Stock Based Compensation
4.19
-42.29%
7.26
+6.19%
6.84
-63.28%
18.62
Asset Impairment Charge
17.53
0.00
-100.00%
7.42
-85.47%
51.05
Deferred Tax
-1.98
-424.14%
-0.38
+0.00%
-0.38
+89.90%
-3.73
Deferred Income Tax
-1.98
-424.14%
-0.38
+0.00%
-0.38
+89.90%
-3.73
Operating Gains Losses
0.36
+215.38%
-0.31
-120.21%
1.54
+3385.11%
-0.05
Gain Loss On Investment Securities
—
-0.00
-101.12%
0.18
—
Net Foreign Currency Exchange Gain Loss
0.15
+129.88%
-0.51
-842.03%
0.07
+246.81%
-0.05
Gain Loss On Sale Of PPE
0.21
+2.48%
0.20
-84.43%
1.30
0.00
Change In Working Capital
2.77
+345.79%
-1.13
+84.94%
-7.48
-165.46%
11.43
Change In Receivables
0.11
+133.33%
-0.32
+36.69%
-0.51
-785.14%
0.07
Changes In Account Receivables
0.11
+133.33%
-0.32
+36.69%
-0.51
-785.14%
0.07
Change In Inventory
-0.33
-17.33%
-0.28
0.00
0.00
Change In Prepaid Assets
0.41
+115.26%
0.19
-90.21%
1.94
+57.09%
1.24
Change In Payables And Accrued Expense
1.47
+277.97%
-0.83
+90.93%
-9.11
-183.73%
10.88
Change In Accrued Expense
1.18
+141.22%
0.49
+105.47%
-8.96
-186.03%
10.41
Change In Payable
0.29
+121.88%
-1.32
-760.13%
-0.15
-132.62%
0.47
Change In Account Payable
0.29
+121.88%
-1.32
-760.13%
-0.15
-132.62%
0.47
Change In Other Working Capital
0.79
+504.64%
-0.19
-161.59%
0.32
+252.17%
-0.21
Change In Other Current Assets
0.03
-86.70%
0.22
+186.85%
-0.25
+68.63%
-0.80
Change In Other Current Liabilities
0.29
+255.42%
0.08
-35.66%
0.13
-48.40%
0.25
Investing Cash Flow
29.37
+246.49%
-20.05
-156.59%
35.43
+142.59%
14.61
Cash Flow From Continuing Investing Activities
29.37
+246.49%
-20.05
-156.59%
35.43
+142.59%
14.61
Net PPE Purchase And Sale
-4.21
-52.04%
-2.77
+16.23%
-3.30
+53.94%
-7.17
Purchase Of PPE
-4.21
-52.04%
-2.77
+16.23%
-3.30
+53.94%
-7.17
Capital Expenditure
-4.21
-52.04%
-2.77
+16.23%
-3.30
+53.94%
-7.17
Net Investment Purchase And Sale
33.80
+295.01%
-17.33
-144.31%
39.11
+79.59%
21.78
Purchase Of Investment
0.00
+100.00%
-58.52
0.00
+100.00%
-9.46
Sale Of Investment
33.80
-17.95%
41.19
+5.31%
39.11
+25.18%
31.24
Net Business Purchase And Sale
-0.20
0.00
0.00
0.00
Purchase Of Business
-0.20
0.00
0.00
0.00
Net Other Investing Changes
-0.01
-132.61%
0.05
+112.33%
-0.37
—
Financing Cash Flow
21.37
-45.91%
39.50
+44.96%
27.25
+3289.55%
0.80
Cash Flow From Continuing Financing Activities
21.37
-45.91%
39.50
+44.96%
27.25
+3289.55%
0.80
Net Issuance Payments Of Debt
—
—
0.00
0.00
Issuance Of Debt
—
—
0.00
0.00
Long Term Debt Issuance
—
—
0.00
0.00
Net Long Term Debt Issuance
—
—
0.00
0.00
Net Common Stock Issuance
21.20
-43.95%
37.83
+39.41%
27.14
0.00
Proceeds From Stock Option Exercised
0.16
-90.24%
1.67
+84.94%
0.90
-4.85%
0.95
Net Other Financing Charges
—
—
-0.79
-444.83%
-0.14
Changes In Cash
9.95
+158.02%
-17.14
-195.74%
17.91
+164.01%
-27.98
Effect Of Exchange Rate Changes
-0.10
-240.28%
0.07
+220.00%
-0.06
+77.61%
-0.27
Beginning Cash Position
39.30
-30.28%
56.38
+46.32%
38.53
-42.30%
66.77
End Cash Position
49.15
+25.05%
39.30
-30.28%
56.38
+46.32%
38.53
Free Cash Flow
-45.00
-14.31%
-39.37
+18.13%
-48.08
+4.90%
-50.56
Interest Paid Supplemental Data
0.13
-5.71%
0.14
-6.04%
0.15
+65.56%
0.09
Income Tax Paid Supplemental Data
0.18
+247.17%
0.05
+1666.67%
0.00
-97.96%
0.15
Amortization Of Securities
0.11
+141.54%
-0.26
-135.37%
0.73
-47.42%
1.40
Common Stock Issuance
21.20
-43.95%
37.83
+39.41%
27.14
0.00
Issuance Of Capital Stock
21.20
-43.95%
37.83
+39.41%
27.14
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category